Removal of Benign and Malignant Skin Lesions Form

Chat with GenHealth to automate any policy or prior auth task.


Removal of Benign Skin Lesions

Indications

(920060) Is the removal of the skin lesion medically necessary due to bleeding? 
(920061) Is the skin lesion causing persistent or intense itching? 
(920062) Is the patient experiencing pain from the lesion? 
(920063) Is there physical evidence of inflammation such as purulence, oozing, edema, or erythema present? 
(920064) Does the lesion obstruct an orifice or clinically restrict vision? 

YesNoN/A
YesNoN/A
YesNoN/A

Sign up to see the rest of the questions

Unlock the remaining questions and the full coverage workflow.

Sign up for free
Effective Date

10/24/2019

Last Reviewed

10/14/2019

Original Document

  Reference



Background for this Policy

Summary Of Evidence

N/A

Analysis of Evidence

N/A

Benign skin lesions are common in the elderly and are sometimes removed at the patient's request. Removal of certain benign skin lesions that do not pose a threat to health or function are considered cosmetic, and as such, are not covered by the Medicare program (statutory exclusion). This LCD describes the medical conditions for which skin lesion removal using one of the services (eg., shaving, removal, destruction, etc.) listed in the CPT section of the related billing and coding article A56346 would be medically necessary and would therefore not be excluded.

Medicare would consider the removal of any malignant lesion to be medically necessary. Actinic keratosis removals are covered as per the requirements indicated in the CMS Internet-Only Manual, Pub. 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 4, §250.4.

There may be instances in which the removal of benign seborrheic keratoses, sebaceous cysts and viral warts is medically appropriate. Medicare will, therefore, consider their removal as medically necessary and not cosmetic if one or more of the following conditions are present and clearly documented in the medical record:

  • The lesion has one or more of the following characteristics:

    • Bleeding
    • Persistent or intense itching
    • Pain
  • The lesion has physical evidence of inflammation (purulence, oozing, edema, erythema, etc.)
  • The lesion obstructs an orifice or clinically restricts vision
  • There is clinical uncertainty as to the likely diagnosis, particularly where malignancy is a realistic consideration based on lesional appearance, such as increased rate of growth and/or color changes
  • The lesion is in an anatomical region subject to recurrent physical trauma and there is documentation that such trauma has in fact occurred
  • Wart destruction will be covered if it falls under one of the conditions of the first five bullets above. In addition, because warts are a viral infection of the skin, wart destruction will be covered when any one of the following clinical circumstances is present:

    • Periocular warts associated with chronic recurrent conjunctivitis thought secondary to lesional virus shedding
    • Warts of recent origin in immunosuppressed patients

Lesions in sensitive anatomic locations that are non-problematic do not qualify for removal coverage on the basis of location alone.

The type of removal is at the discretion of the treating physician and the appropriateness of the technique used will not be a factor in deciding if a lesion merits removal. However, a benign lesional excision must have medical record documentation as to why an excisional removal, other than for cosmetic purposes, was the surgical procedure of choice.

The decision to submit a specimen for pathologic interpretation will be independent of the decision to remove or not remove the lesion. It is assumed, however, that a tissue diagnosis will be part of the medical record when an ultimately benign lesion is removed based on physician uncertainty as to the final clinical diagnosis.

Office visits will be covered when the diagnosis of a benign skin lesion(s) is made, even if the removal of a particular lesion(s) is not medically indicated and is therefore not done.

Book a walkthrough

Walk through this policy with us

Review how this policy can be converted into cited criteria, prior authorization checks, and operational automation.